EU General Court finds no genuine use of FEMIBION mark for pharmaceuticals
The EU General Court has annulled an EU Intellectual Property Office Board of Appeal decision, instead holding that registration of the EU word mark FEMIBION does not cover pharmaceutical preparations and instead covers only dietetic substances.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10